Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trans-ancestry genome-wide association meta-analysis of antidepressant response to selective serotonin reuptake inhibitors in clinical studies of depression.

medRxiv : the preprint server for health sciences·2026
Same author

Genetics of monozygotic twins reveals the impact of environmental sensitivity on psychiatric and neurodevelopmental phenotypes.

Nature human behaviour·2025
Same author

Optimizing the Prediction of Depression Remission: A Longitudinal Machine Learning Approach.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2024
Same author

Genetics of environmental sensitivity to psychiatric and neurodevelopmental phenotypes: evidence from GWAS of monozygotic twins.

Research square·2024
Same author

Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data.

Translational psychiatry·2024
Same author

Interplay between polygenic risk for mood disorders and stressful life events in bipolar disorder.

Journal of affective disorders·2024
Same journal

Reductions in posttraumatic stress disorder re-experiencing frequency from repetitive transcranial magnetic stimulation combined with Cognitive Processing Therapy.

International review of psychiatry (Abingdon, England)·2026
Same journal

Continuous theta burst stimulation to the frontal pole durably decreases medial frontoamygdala connectivity.

International review of psychiatry (Abingdon, England)·2026
Same journal

What are the arguments for and against recognizing 'terminal' anorexia nervosa? A narrative review.

International review of psychiatry (Abingdon, England)·2026
Same journal

Behavioral addictions in adolescents in Latin America: a narrative review of prevalence, mental health comorbidities, and gaps in care.

International review of psychiatry (Abingdon, England)·2026
Same journal

Persistent suicidality: a concept analysis using Rodgers' evolutionary approach.

International review of psychiatry (Abingdon, England)·2026
Same journal

Extending the evidence for Scrambler Therapy to reduce pain in chemotherapy-induced peripheral neuropathy.

International review of psychiatry (Abingdon, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

The Mouse Forced Swim Test
06:19

The Mouse Forced Swim Test

Published on: January 29, 2012

Gender differences in antidepressant drug response.

Robert Keers1, Katherine J Aitchison

  • 1MRC SGDP Centre, Institute of Psychiatry, King's College London, 16 De Crespigny Park, Denmark Hill, London, UK. robert.keers@kcl.ac.uk

International Review of Psychiatry (Abingdon, England)
|November 5, 2010
PubMed
Summary
This summary is machine-generated.

Gender significantly impacts depression prevalence, symptoms, and antidepressant effectiveness. Differences in metabolism and hormonal factors necessitate personalized treatment approaches, considering genetic variations for optimal outcomes.

More Related Videos

An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression
06:27

An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression

Published on: July 11, 2025

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Related Experiment Videos

Last Updated: Jun 7, 2026

The Mouse Forced Swim Test
06:19

The Mouse Forced Swim Test

Published on: January 29, 2012

An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression
06:27

An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression

Published on: July 11, 2025

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Area of Science:

  • Pharmacology
  • Psychiatry
  • Epidemiology

Background:

  • Depression prevalence and symptoms differ between men and women.
  • Biological factors like metabolism and oestrogen influence antidepressant action.
  • Existing research on gender-specific antidepressant efficacy is controversial.

Purpose of the Study:

  • To explore gender differences in depression prevalence and presentation.
  • To investigate potential gender-based variations in antidepressant efficacy and tolerability.
  • To examine the impact of genetic factors on antidepressant response.

Main Methods:

  • Review of epidemiological studies on depression in men and women.
  • Analysis of pharmacological differences in antidepressant metabolism and distribution.
  • Consideration of hormonal influences and genetic variability.

Main Results:

  • Women exhibit higher depression rates and more anxiety symptoms.
  • Antidepressant metabolism and oestrogen levels present gender-specific challenges.
  • Selective serotonin re-uptake inhibitors (SSRIs) may show differential efficacy compared to tricyclic antidepressants (TCAs) across genders.

Conclusions:

  • Gender is a critical factor in depression presentation and treatment response.
  • Further research is needed to clarify gender-specific antidepressant efficacy and safety.
  • Personalized treatment strategies incorporating genetic profiles are essential for optimizing antidepressant therapy.